Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
International Journal of Cancer
|
December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
Christine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR
|
August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
Maximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Ebiomedicine
|
July 11, 2020
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'
Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, et al.
Ebiomedicine
|
April 7, 2019
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, et al.
International Journal of Cancer
|
October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
Elodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
BMC Cancer
|
January 14, 2016
GENESIS: a French national resource to study the missing heritability of breast cancer
Olga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
International Journal of Cancer
|
December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
Christine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR
|
August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
Maximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Ebiomedicine
|
July 11, 2020
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'
Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, et al.
Ebiomedicine
|
April 7, 2019
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, et al.
International Journal of Cancer
|
October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
Elodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
BMC Cancer
|
January 14, 2016
GENESIS: a French national resource to study the missing heritability of breast cancer
Olga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
Page
of 10